hydroxyurea has been researched along with Acute Kidney Failure in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a prospective, randomized, Phase II study of deferasirox and deferoxamine (DFO) in sickle cell disease patients with transfusional iron overload, with all patients continuing on deferasirox after 24 weeks, for up to 2 years." | 5.17 | Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea. ( Barrette, S; Files, B; Habr, D; Minniti, CP; Torres, M; Vichinsky, E; Zhang, Y, 2013) |
| "A 63-year-old patient with primary myelofibrosis underwent kidney biopsy to investigate nephrotic-range proteinuria and reduced kidney function." | 1.46 | Membranous Nephropathy and Intrarenal Extramedullary Hematopoiesis in a Patient With Myelofibrosis. ( Aniort, J; Heng, AE; Kemeny, JL; Philipponnet, C; Ronco, P, 2017) |
| "BW B70C treatment did not improve the long-term viability of transplanted kidneys: 2/6 rabbits showed no symptoms of renal failure after 3 weeks." | 1.29 | Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation. ( Fuller, BJ; Green, CJ; Lane, NJ; Manek, S; Thorniley, MS, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philipponnet, C | 1 |
| Ronco, P | 1 |
| Aniort, J | 1 |
| Kemeny, JL | 1 |
| Heng, AE | 1 |
| Park, F | 1 |
| Soni, H | 1 |
| Pressly, JD | 1 |
| Adebiyi, A | 1 |
| Vichinsky, E | 1 |
| Torres, M | 1 |
| Minniti, CP | 1 |
| Barrette, S | 1 |
| Habr, D | 1 |
| Zhang, Y | 1 |
| Files, B | 1 |
| Lane, NJ | 1 |
| Thorniley, MS | 1 |
| Manek, S | 1 |
| Fuller, BJ | 1 |
| Green, CJ | 1 |
1 trial available for hydroxyurea and Acute Kidney Failure
| Article | Year |
|---|---|
Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.
Topics: Acute Kidney Injury; Adolescent; Adult; Anemia, Sickle Cell; Benzoates; Cellulitis; Chelation Therap | 2013 |
3 other studies available for hydroxyurea and Acute Kidney Failure
| Article | Year |
|---|---|
Membranous Nephropathy and Intrarenal Extramedullary Hematopoiesis in a Patient With Myelofibrosis.
Topics: Acute Kidney Injury; Antineoplastic Agents; Edema; Glomerulonephritis, Membranous; Hematopoiesis, Ex | 2017 |
Acute hydroxyurea treatment reduces tubular damage following bilateral ischemia-reperfusion injury in a mouse model of sickle cell disease.
Topics: Acute Kidney Injury; Anemia, Sickle Cell; Animals; Antisickling Agents; Biomarkers; Creatinine; Dise | 2019 |
Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation.
Topics: Acute Kidney Injury; Animals; Capillary Permeability; Creatinine; Disease Models, Animal; Eicosanoid | 1994 |